Koyfin Home > Directory > Health Care > Anika Therapeutics > Long-term Debt / Equity

Anika Therapeutics Long-term Debt / Equity Chart (ANIK)

Anika Therapeutics annual/quarterly Long-term Debt / Equity from 2010 to 2020.
  • Anika Therapeutics Long-term Debt / Equity for the quarter ending June 06, 2020 was $25m a 69.21% increase of 17m year over year
  • Anika Therapeutics Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $25m a 69.21% increase of 17m year over year
  • Anika Therapeutics Annual Long-term Debt / Equity for 2019 was $7m a 0.88% increase of 0m from 2018
  • Anika Therapeutics Annual Long-term Debt / Equity for 2012 was $7m a -37.94% decrease of -3m from 2011
  • Anika Therapeutics Annual Long-term Debt / Equity for 2011 was $10m a -29.78% decrease of -3m from 2010
Other Ratios Metrics:
  • Anika Therapeutics Total Debt / Capital for the quarter ending September 09, 2013 was $6m a -31.72% decrease of -2m year over year
  • Anika Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $4m a -57.58% decrease of -2m year over year
  • Anika Therapeutics Total Debt / Equity for the quarter ending September 09, 2013 was $7m a -34.52% decrease of -2m year over year
View Chart On Koyfin

Quarterly ANIK Long-term Debt / Equity Data

06/2020$25m
03/2020$8m
12/2019$7m
09/2019$8m
06/2019$9m
03/2019$8m
09/2013$5m
06/2013$6m
03/2013$7m
12/2012$7m

Annual ANIK Long-term Debt / Equity Data

2019$7m
2012$7m
2011$10m
2010$13m